Brief: Xiangmin Cui Reports 8.0% Stake In Nuvation Bio As Of September 3- SEC Filing
10/09/2024 23:07
Nuvation Bio Inc NUVB.N :
* XIANGMIN CUI REPORTS 8.0% STAKE IN NUVATION BIO AS OF
SEPTEMBER
3- SEC FILING
Source text for Eikon: ID:n0001104659-24-098630
Further company coverage: NUVB.N
Recent news on Nuvation Bio
See all newsBrief: Nuvation Bio To Expand Pivotal Phase 3 Sigma Study Of Safusidenib For Idh1-Mutant Glioma To Six European Countries
Brief: Nuvation Bio To Report Third Quarter 2026 Financial Results And Provide Business Update On November 4, 2026
U.S. RESEARCH ROUNDUP-Everpure, Marvell Technology, Okta
Nuvation Bio Inc. reports results for the quarter ended June 30 - Earnings Summary
Nuvation Bio Q2 revenue beats estimates on IBTROZI growth